New Cures 2.0 Bill Extends Key Telehealth Flexibilities, Hastens CMS Approval of Medical Devices

The bill would allow CMS to temporarily cover breakthrough products approved by FDA for four years. The agency will have to make a permanent coverage determination in those four years. It also calls for the Government Accountability Office to offer recommendations on how to enhance Medicare coverage and reimbursement of innovative health technologies.

Source: https://www.fiercehealthcare.com/payer/new-cures-2-0-bill-extends-key-telehealth-flexibilities-and-hastens-cms-approval-medical